Editorial: Pathogenesis, treatment, and future directions for rare T-cell leukemias

Detalles Bibliográficos
Autores principales: Herling, Marco, Jarjour, Wael, Mishra, Anjali, Brammer, Jonathan E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9490408/
https://www.ncbi.nlm.nih.gov/pubmed/36158669
http://dx.doi.org/10.3389/fonc.2022.991527
_version_ 1784793078877388800
author Herling, Marco
Jarjour, Wael
Mishra, Anjali
Brammer, Jonathan E.
author_facet Herling, Marco
Jarjour, Wael
Mishra, Anjali
Brammer, Jonathan E.
author_sort Herling, Marco
collection PubMed
description
format Online
Article
Text
id pubmed-9490408
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-94904082022-09-22 Editorial: Pathogenesis, treatment, and future directions for rare T-cell leukemias Herling, Marco Jarjour, Wael Mishra, Anjali Brammer, Jonathan E. Front Oncol Oncology Frontiers Media S.A. 2022-09-07 /pmc/articles/PMC9490408/ /pubmed/36158669 http://dx.doi.org/10.3389/fonc.2022.991527 Text en Copyright © 2022 Herling, Jarjour, Mishra and Brammer https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Herling, Marco
Jarjour, Wael
Mishra, Anjali
Brammer, Jonathan E.
Editorial: Pathogenesis, treatment, and future directions for rare T-cell leukemias
title Editorial: Pathogenesis, treatment, and future directions for rare T-cell leukemias
title_full Editorial: Pathogenesis, treatment, and future directions for rare T-cell leukemias
title_fullStr Editorial: Pathogenesis, treatment, and future directions for rare T-cell leukemias
title_full_unstemmed Editorial: Pathogenesis, treatment, and future directions for rare T-cell leukemias
title_short Editorial: Pathogenesis, treatment, and future directions for rare T-cell leukemias
title_sort editorial: pathogenesis, treatment, and future directions for rare t-cell leukemias
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9490408/
https://www.ncbi.nlm.nih.gov/pubmed/36158669
http://dx.doi.org/10.3389/fonc.2022.991527
work_keys_str_mv AT herlingmarco editorialpathogenesistreatmentandfuturedirectionsforraretcellleukemias
AT jarjourwael editorialpathogenesistreatmentandfuturedirectionsforraretcellleukemias
AT mishraanjali editorialpathogenesistreatmentandfuturedirectionsforraretcellleukemias
AT brammerjonathane editorialpathogenesistreatmentandfuturedirectionsforraretcellleukemias

Ejemplares similares